| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Mendelson Daniel Newman is a Director at CHAMPIONS ONCOLOGY, INC.. Recent SEC Form 4 filings include 12 buys and 2 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 5,000 | $5.65 | $28,250.00 | +3.5% | -11.3% | -14.2% | |
| Sep 22, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 3,812 | $5.50 | $20,966.00 | +2.8% | -9.1% | -11.7% | |
| Sep 21, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 5,000 | $5.51 | $27,550.00 | +3.8% | -6.8% | -10.5% | |
| Sep 20, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 4,018 | $5.51 | $22,139.18 | +3.1% | -14.8% | -8.6% | |
| Sep 19, 2023 | CSBR Champions Oncology, Inc. | Director | Buy | 5,000 | $5.28 | $26,400.00 | +4.1% | -11.1% | -17.9% | |
| Mar 26, 2020 | CSBR Champions Oncology, Inc. | Director | Buy | 1,220 | $5.91 | $7,213.00 | +0.4% | - | - | |
| Mar 24, 2020 | CSBR Champions Oncology, Inc. | Director | Buy | 26 | $5.50 | $143.00 | - | - | - | |
| Nov 6, 2018 | CSBR Champions Oncology, Inc. | Director | Sell | 5,000 | $13.75 | $68,750.00 | -8.0% | - | - | |
| Sep 20, 2018 | CSBR Champions Oncology, Inc. | Director | Sell | 8,333 | $13.02 | $108,495.66 | -11.8% | - | - | |
| Mar 11, 2015 | CSBR Champions Oncology, Inc. | Director | Buy | 750,000 | $0.00 | - | New | - | - |